Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

KZIA

Kazia Therapeutics (KZIA)

Kazia Therapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KZIA
DateTimeSourceHeadlineSymbolCompany
09/27/20106:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
09/22/20108:00AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
09/20/20108:00AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
09/20/20108:00AMMarketwiredNovogen Appoints Three New DirectorsNASDAQ:KZIAKazia Therapeutics Ltd
09/08/20108:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
09/08/20108:00AMPR Newswire (US)Marshall Edwards Reaches Agreement in Principle to Acquire Intellectual Property Portfolio From NovogenNASDAQ:KZIAKazia Therapeutics Ltd
08/31/20109:00AMPR Newswire (US)Marshall Edwards to Host Conference Call on September 8, 2010NASDAQ:KZIAKazia Therapeutics Ltd
08/26/20108:36AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
08/11/20107:54AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
08/10/20107:30AMPR Newswire (US)Marshall Edwards Appoints Oncologist Christine White to Board of DirectorsNASDAQ:KZIAKazia Therapeutics Ltd
07/23/20108:00AMMarketwiredNovogen Limited Receives Nasdaq NoticeNASDAQ:KZIAKazia Therapeutics Ltd
06/21/20106:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
06/18/20109:00AMMarketwiredNovogen Restructures Australian Management Team and Marshall Edwards Appoints CFONASDAQ:KZIAKazia Therapeutics Ltd
06/17/20109:00AMMarketwiredMarshall Edwards Announces Additional Management Changes With Appointment of New Chief Financial OfficerNASDAQ:KZIAKazia Therapeutics Ltd
06/03/20108:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
06/03/20108:00AMMarketwiredMarshall Edwards' CEO to Present at Needham Healthcare ConferenceNASDAQ:KZIAKazia Therapeutics Ltd
06/01/20108:38AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
06/01/20108:30AMMarketwiredMarshall Edwards Announces Final Results From Halted Phase 3 Clinical Trial of PhenoxodiolNASDAQ:KZIAKazia Therapeutics Ltd
05/24/20108:30AMMarketwiredMarshall Edwards, Inc. Receives Nasdaq Notice of Minimum Stockholders' Equity Non-ComplianceNASDAQ:KZIAKazia Therapeutics Ltd
05/21/20109:13AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
05/21/20109:00AMMarketwiredReport on Phase II Clinical Study of Marshall Edwards' Phenoxodiol in Prostate Cancer to Be Presented at ASCONASDAQ:KZIAKazia Therapeutics Ltd
05/18/20106:02AMEdgar (US Regulatory)Amended Annual and Transition Report (foreign private issuer) (20-F/A)NASDAQ:KZIAKazia Therapeutics Ltd
05/06/20108:00AMMarketwiredMarshall Edwards Appoints CEO as a New DirectorNASDAQ:KZIAKazia Therapeutics Ltd
04/29/20108:00AMMarketwiredMarshall Edwards, Inc. Announces Grants Under Nasdaq Rule 5635NASDAQ:KZIAKazia Therapeutics Ltd
04/27/20106:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
04/26/20108:00AMMarketwiredMarshall Edwards Appoints New President and CEONASDAQ:KZIAKazia Therapeutics Ltd
04/20/20109:00AMMarketwiredMarshall Edwards, Inc. Receives Notice of Compliance With Nasdaq Continued Listing RequirementsNASDAQ:KZIAKazia Therapeutics Ltd
03/31/20108:00AMMarketwiredMarshall Edwards, Inc. Announces Stockholder Approval and Implementation of 1:10 Reverse Stock SplitNASDAQ:KZIAKazia Therapeutics Ltd
03/31/20108:00AMMarketwiredNovogen Announces New Executive Service AgreementsNASDAQ:KZIAKazia Therapeutics Ltd
03/31/20107:58AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:KZIAKazia Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:KZIA